These systemic manifestations arise from an inflammatory syndrome and result in elevated levels of inflammatory chemokines, alarmins, and serum interleukin-6 (IL-6), profound lymphopenia, coagulopathy, direct infection of pulmonary capillary endothelial cells, or hyperactivated innate immune defenses [7,8]. This evidence concerns the gene IL6 and lymphopenia.